SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $43.72 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-09-04.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2024-09-04
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-06-30 was $39.68K, a 2175.40% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-03-31 was $4.04K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2023-06-30 was $1.74K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2023-03-31 was $0.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2023 was $4.97K.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|---|
| 2024-06-30 | $39.68K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-09-04 | $43.72K 10-Q · filed 2024-09-04 | |
| 2024-03-31 | $4.04K 10-Q/A · filed 2024-09-04 | ||
| 2023-12-31 | $4.97K 10-K/A · filed 2024-09-04 | ||
| 2023-06-30 | $1.74K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-09-04 | $1.74K 10-Q · filed 2024-09-04 | |
| 2023-03-31 | $0.00 10-Q/A · filed 2024-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |